Cytomegalovirus (CMV) Infection- More novel therapies required

Cytomegalovirus (CMV) Infection, caused by a common virus in the same family as herpes virus, and it can infect people of all ages. CMV also includes the herpes simplex viruses and the viruses that cause chickenpox and mononucleosis (mono). According to the estimations over half of all adults have been infected with CMV during their lifetime. Researchers are aggressively working to bring new prophylaxis as …

Read More

Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) – Scarcity of drugs in the pipeline

Adenosine deaminase (ADA) deficiency is an ultra-rare inherited disorder that damages the immune system and causes severe combined immunodeficiency (SCID). It is the second most prevalent form of SCID comprising of almost 15% – 20% of all SCID cases. It is characterized by profound immune deficiency condition resulting in a weak immune system that is unable to fight off even mild infections. Affected infants often …

Read More

PARP INHIBITORS- Back to Back drug approval boosting the market

Product pipeline of PARP is highly active with more than 30% of the products in Phase III as per the latest report of DelveInsight. Poly (ADP-ribose) polymerase has emerged as a promising anti-cancer target in the past decade. PARPs are activated by DNA damage and plays an essential role in the repair of DNA Evidences have shown that tumor cells subjected to radio- or chemotherapy …

Read More

Spinal Muscular Atrophy – Global market size will increase 2 folds by 2025

Spinal Muscular Atrophy (SMA) is a neuromuscular disorder caused by Bi-allelic mutation of survival motor neuron gene 1 (SMN1). In healthy people this gene produces a protein required by the muscle controlling nerves. In the deficiency of this protein these nerve cells cannot function properly which leads to fatal muscle weakness. It is one of the most common causes of infant death and mobility impairment. …

Read More